Axes 1–2
Traceability and studiedness
Scored from the available data. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 14.3%. Potency: Potency is stated through expiry.
product · release 2026-09-20
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Printed organisms · observed
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus acidophilus La-14 | Lactobacillus acidophilus | La-14 | not printed | not printed | T2; observed; quantity unavailable |
| Lactobacillus paracasei LPC-37 | Lacticaseibacillus paracasei | Lpc-37 | not printed | not printed | T2; observed; quantity unavailable |
| Bifidobacterium animalis lactis BL-04 | Bifidobacterium animalis | Bl-04 | not printed | not printed | T2; observed; quantity unavailable |
| Bifidobacterium bifidum BB-6 | Bifidobacterium bifidum | BB-6 | not printed | not printed | T3; observed; quantity unavailable |
| Lactobacillus plantarum Lp-115 | Lactiplantibacillus plantarum | Lp-115 | not printed | not printed | T1; observed; quantity unavailable |
| Lactobacillus rhamnosus LR-32 | Lacticaseibacillus rhamnosus | Lr-32 | not printed | not printed | T3; observed; quantity unavailable |
| Saccharomyces boulardii | Saccharomyces boulardii | not printed | not printed | 2,000,000,000 CFU | T4; observed; quantity printed |
Pack, dose and cost
Printed potency
2,000,000,000 CFU per serving across 1 of 7 printed organism rows; potency basis Potency is stated through expiry. 6 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Bifidobacterium animalis | 423 |
| Bifidobacterium animalis subsp. lactis Bl-04 | 12 |
| Bifidobacterium bifidum | 136 |
| Bifidobacterium bifidum BB-6 | 0 |
| Lacticaseibacillus paracasei | 180 |
| Lacticaseibacillus paracasei Lpc-37 | 10 |
| Lacticaseibacillus rhamnosus | 465 |
| Lacticaseibacillus rhamnosus Lr-32 | 1 |
| Lactiplantibacillus plantarum | 267 |
| Lactiplantibacillus plantarum Lp-115 | 0 |
| Lactobacillus acidophilus | 381 |
| Lactobacillus acidophilus La-14 | 6 |
| Saccharomyces boulardii | 116 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
This formulation scores above 19.2% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| Nature's Bounty Acidophilus Probiotic | La-14 | 89.63 | not observed |
| Puritan's Pride Probiotic Acidophilus | La-14 | 89.63 | not observed |
| NOW Acidophilus Two Billion | La-14 | 89.63 | not observed |
Axes 1–2
Scored from the available data. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 14.3%. Potency: Potency is stated through expiry.
Axes 3–4
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
undefined: no permitted price observation in this release
Sensitivity
Preference interval 48.87–60.42; rank uncertainty 1903.00–2842.00; rank class 4.
Versions
Preference tool
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Elsewhere in this release
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Ivitskiy, I. (2026). HoltraCeuticals UltraBiotics. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/ultrabiotics/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
HoltraCeuticals UltraBiotics: 6 of 7 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 270815. Window: NIH DSLD snapshot Sep 2026.
6 / 7 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437HoltraCeuticals UltraBiotics: 1 of 1 observed label snapshots state a potency basis; latest basis is through expiry. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
1 / 1 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437HoltraCeuticals UltraBiotics: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 58.89 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437HoltraCeuticals UltraBiotics has 1 observed versions across 1 formulation groups; last recorded edge type: same product. Window: NIH DSLD snapshot Sep 2026.
1 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437HoltraCeuticals UltraBiotics: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437